Targeted therapy of Schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin

This publication has 20 references indexed in Scilit:

• Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects
  International Journal of Cancer, 1997
• Schannoma cells induce a tumor-cell-specific cytotoxic- T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factors
  International Journal of Cancer, 1997
• Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
  Journal of Clinical Oncology, 1996
• In Vivo Efficacy of Intrathecal Transferrin-Pseudomonas Exotoxin A Immunotoxin against LOX Melanoma
  Neurosurgery, 1994
• The epidermal growth factor receptor as a target for therapy in breast carcinoma
  Breast Cancer Research and Treatment, 1994
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
  Journal of Clinical Investigation, 1993
• Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers
  British Medical Bulletin, 1991
• Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli
  Cell, 1987
• Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
  Proceedings of the National Academy of Sciences, 1986
• [16] Plasmids of Escherichia coli as cloning vectors
  Published by Elsevier ,1979